16-Jan-2020 | Facts and Factors
Facts and Factors Market Research has published a new report titled “North America Fetal Surgery Market By Method (Invasive and Minimally Invasive), by Surgical Procedure (Intrauterine Transfusion, Fetoscopic Laser Photocoagulation for TTTS, Fetal Shunt Placement, Amniotic Band Resection, Ex-Utero Intrapartum Treatment, Fetoscopic Tracheal Occlusion, and Fetoscopic Spina Bifida Repair), and by Facility (Clinics, Children’s Hospital, and Others): Industry Perspective, Comprehensive Analysis, and Forecast, 2019–2027.” According to the report, the demand for North America fetal surgery market was valued approximately USD 2,356 million in 2018 and is expected to reach around USD 5,079 million by 2027, at a CAGR of around 8.9% between 2019 and 2027.
Fetal surgery is performed on fetuses or unborn babies in case of emergencies, to improve the long-term survival of the fetus post-delivery. For instance, there are times when surgeons perform an open fetal surgery when a fetus is diagnosed with spina bifida, long before its birth. Myelomeningocele, a type of spina bifida, an opening on the back of the fetus, in the uterus, leads to the spinal cord and its covering to be exposed to amniotic fluid. When a doctor finds that an unborn baby has myelomeningocele, he or she generally recommends open fetal surgery as treatment. Fetal surgery offers better results in comparison to surgery post-delivery in some cases.
Browse the full “North America Fetal Surgery Market By Method (Invasive and Minimally Invasive), by Surgical Procedure (Intrauterine Transfusion, Fetoscopic Laser Photocoagulation for TTTS, Fetal Shunt Placement, Amniotic Band Resection, Ex-Utero Intrapartum Treatment, Fetoscopic Tracheal Occlusion, and Fetoscopic Spina Bifida Repair), and by Facility (Clinics, Children’s Hospital, and Others): Industry Perspective, Comprehensive Analysis, and Forecast, 2019–2027” Report at https://www.fnfresearch.com/north-america-fetal-surgery-market-by-method-invasive
Improved level of surgeries majorly driving the North America fetal surgery market
The rise in the use of 3D models by surgeons across North America to plan operations, particularly involving a fetus, is among the prominent factors that have enhanced and elevated the level of surgeries that are being performed. The process of visualization and imaging of the entire surgery along with its minute details helps the surgeons locate potential complications of the case in advance, which helps them proactive during complex surgeries. Surgeons need accurate images of the specific part of the fetus that needs to be operated on. Thus, the process of using 3D images streamlines the entire surgery making it convenient for the doctor. This is the primary growth driver of the North America fetal surgery market.
In addition, the North America fetal surgery market is also fuelled by the growing prevalence of spina bifida, which is a birth defect during a routine anatomy scan.
Invasive surgery is projected to dominate the method segment
The growing demand and need for different types of invasive method for treating congenital diaphragmatic hernia, neural tube defects, pulmonary sequestration, congenital heart disease, sacrococcygeal teratoma, congenital and cystic adenomatoid malformation, due to their growing incidences will be driving the invasive method segment of the North America fetal surgery market in the years ahead. In 2018, the invasive segment was valued USD 1,417 million.
Fetoscopic spina bifida repair is likely to be the largest market segment
The fetoscopic spina bifida repair segment is likely to hold the largest share of the North America fetal surgery market in the upcoming years. In 2018, this segment held 27.7% of the total market share globally, due to the rising procedures of fetoscopic spina bifida repair across North America. This segment will also record the highest CAGR in the future.
The U.S. will dominate the North America fetal surgery market
In 2018, the U.S. contributed a 79.2% share to the overall North America fetal surgery market. This can be due to the increasing number of pre-term births across the country and advanced level of surgeries.
Key players operating in the North America fetal surgery market are The Johns Hopkins Center for Fetal Therapy, University of Michigan Health System, Ohio State Maternal Fetal Medicine, Cincinnati Children's Hospital Medical Center, Abbott Northwestern Hospital, Boston Children's Hospital, Colorado Fetal Care Center, The Children’s Hospital of Philadelphia, UM Baltimore Washington Medical Center, Mayo Foundation for Medical Education and Research, Fetal Health Foundation, Children’s Minnesota, Barnes-Jewish Hospital, SSM Health, and Ochsner Health System, among others.
This report segments the North America fetal surgery market as follows:
North America Fetal Surgery Market: By Method Analysis
- Minimally Invasive
North America Fetal Surgery Market: By Surgical Procedure Analysis
- Intrauterine Transfusion
- Fetoscopic Laser Photocoagulation for TTTS
- Fetal Shunt Placement
- Amniotic Band Resection
- Ex-Utero Intrapartum Treatment (Exit)
- Fetoscopic Tracheal Occlusion (FETO)
- Fetoscopic Spina Bifida Repair
North America Fetal Surgery Market: By Facility Analysis
- Children’s Hospitals
North America Fetal Surgery Market: By Country Analysis
Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds. Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.
Facts & Factors
Level 8, International Finance Center, Tower 2,
8 Century Avenue, Shanghai,
Postal - 200120, China
Tel: +86 21 80360450